Cyclacel Pharmaceuticals, Inc.

[Available On-Demand] ・ Click video to start playback; Join chat Q&A below video
Search General Info
Cyclacel is a clinical-stage biopharmaceutical company developing innovative cancer medicines based on cell cycle, transcriptional regulation and DNA damage response biology.
Ticker:
CYCC; CYCCP
Exchange:
Nasdaq
Company Type:
Company Website:
Company HQ State:
New Jersey
Company HQ Country:
United States
Year Founded:
1997
Main Therapeutic Focus:
Lead Product in Development:
Fadraciclib
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
President and CEO
Cyclacel Pharmaceuticals, Inc.